Post by argenx

At #EULAR2026, we shared new data supporting the safety, tolerability, and clinical potential of efgartigimod across autoimmune rheumatic diseases.   Couldn’t make the presentation? Read more: https://bit.ly/4usOSwG   These findings reflect our ongoing commitment to advancing innovation for people living with these types of diseases.   Thank you to everyone who joined us!   #TogetherWeDiscover